Research Article| Volume 62, ISSUE 4, P831-840, April 2015

The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

Published:November 21, 2014DOI:

      Background & Aims

      Cirrhotic patients with acute decompensation frequently develop acute-on-chronic liver failure (ACLF), which is associated with high mortality rates. Recently, a specific score for these patients has been developed using the CANONIC study database. The aims of this study were to develop and validate the CLIF-C AD score, a specific prognostic score for hospitalised cirrhotic patients with acute decompensation (AD), but without ACLF, and to compare this with the Child-Pugh, MELD, and MELD-Na scores.


      The derivation set included 1016 CANONIC study patients without ACLF. Proportional hazards models considering liver transplantation as a competing risk were used to identify score parameters. Estimated coefficients were used as relative weights to compute the CLIF-C ADs. External validation was performed in 225 cirrhotic AD patients. CLIF-C ADs was also tested for sequential use.


      Age, serum sodium, white-cell count, creatinine and INR were selected as the best predictors of mortality. The C-index for prediction of mortality was better for CLIF-C ADs compared with Child-Pugh, MELD, and MELD-Nas at predicting 3- and 12-month mortality in the derivation, internal validation and the external dataset. CLIF-C ADs improved in its ability to predict 3-month mortality using data from days 2, 3–7, and 8–15 (C-index: 0.72, 0.75, and 0.77 respectively).


      The new CLIF-C ADs is more accurate than other liver scores in predicting prognosis in hospitalised cirrhotic patients without ACLF. CLIF-C ADs therefore may be used to identify a high-risk cohort for intensive management and a low-risk group that may be discharged early.


      ACLF (acute-on-chronic liver failure), AD (acute decompensation), CANONIC study (EASL-CLIF Acute oN chrONIC liver failure study), CLIF (Chronic Liver Failure), CLIF-C ACLFs (CLIF-CONSORTIUM ACLF score), CLIF-C OFs (CLIF-Consortium Organ Failure score), CLIF-SOFAs (CLIF-Sequential Organ Failure Assessment score), CPs (Child-Pugh score), E (epinephrine), EASL (European Association for the Study of the Liver), FIO2 (fraction of inspired oxygen), HE (hepatic encephalopathy), INR (International Normalized Ratio), MAP (mean arterial pressure), MELDs (Model of End-Stage Liver Disease), MELD-Nas (MELD-Sodium score), NE (norepinephrine), PaO2 (partial pressure of arterial oxygen), SOFA (Sequential Organ Failure Assessment), SpO2 (pulse oximetric saturation)


      Linked Article

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jalan R.
        • Gines P.
        • Olson J.C.
        • et al.
        Acute-on chronic liver failure.
        J Hepatol. 2012; 57: 1336-1348
        • Jalan R.
        • Yurdaydin C.
        • Bajaj J.S.
        • et al.
        Toward an improved definition of acute-on-chronic liver failure.
        Gastroenterology. 2014; 147: 4-10
        • Jalan R.
        • Saliba F.
        • Pavesi M.
        • et al.
        Development and validation of a prognostic score to predict mortality in patients with acute on chronic liver failure.
        J Hepatol. 2014; 61: 1038-1047
        • Jalan R.
        • Williams R.
        Acute-on-chronic liver failure: pathophysiological basis of therapeutic options.
        Blood Purif. 2002; 20: 252-261
        • Moreau R.
        • Jalan R.
        • Gines P.
        • et al.
        Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute decompensation in cirrhosis.
        Gastroenterology. 2013; 144: 1426-1437
        • Olson J.C.
        • Wendon J.A.
        • Kramer D.J.
        • et al.
        Intensive care of the patient with cirrhosis.
        Hepatology. 2011; 54: 1864-1872
        • Kamath P.S.
        • Kim W.R.
        The model for end-stage liver disease (MELD).
        Hepatology. 2007; 45: 797-805
        • Kim W.R.
        • Biggins S.W.
        • Kremers W.K.
        • et al.
        Hyponatremia and mortality among patients on the liver-transplant waiting list.
        N Engl J Med. 2008; 359: 1018-1026
        • Pugh R.N.
        • Murray-Lyon I.M.
        • Dawson J.L.
        • Pietroni M.C.
        • Williams R.
        Transection of the oesophagus for bleeding oesophageal varices.
        Br J Surg. 1973; 60: 646-649
        • Ferreira F.L.
        • Bota D.P.
        • Bross A.
        • Melot C.
        • Vincent J.L.
        Serial evaluation of the SOFA score to predict outcome in critically ill patients.
        JAMA. 2001; 286: 1754-1758
        • Fine J.P.
        • Gray R.J.
        A proportional hazards model for the subdistribution of a competing risk.
        J Am Stat Assoc. 1999; 94: 496-509
        • Wolbers M.
        • Koller M.T.
        • Witteman J.C.
        • Steyerberg E.W.
        Prognostic models with competing risks. methods and application to coronary risk prediction.
        Epidemiology. 2009; 20: 555-561
        • Harrell Jr., F.E.
        • Lee K.L.
        • Mark D.B.
        Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.
        Stat Med. 1996; 15: 361-368
        • Pencina M.J.
        • D’Agostino R.B.
        Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.
        Stat Med. 2004; 23: 2109-2123
        • Pencina M.J.
        • D’Agostino Sr., R.B.
        • D’Agostino Jr., R.B.
        • Vasan R.S.
        Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
        Stat Med. 2008; 27: 157-172
        • Altman D.G.
        • Royston P.
        What do we mean by validating a prognostic model?.
        Stat Med. 2000; 19: 453-473
        • Jalan R.
        • Stadlbauer V.
        • Sen S.
        • Cheshire L.
        • Chang Y.M.
        • Mookerjee R.P.
        Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study.
        Crit Care. 2012; 16: R227
        • Schepke M.
        • Roth F.
        • Fimmers R.
        • et al.
        Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
        Am J Gastroenterol. 2003; 98: 1167-1174
        • Chologitas E.
        • Marelli L.
        • Shusang V.
        • et al.
        A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation.
        Liver Transpl. 2006; 12: 1049-1061
        • Murad S.D.
        • Ray Kim W.
        • de Groen P.C.
        Can the model for end-stage liver disease be used to predict the prognosis in patients with vBudd-Chiari syndrome?.
        Liver Transpl. 2007; 13: 867-874
        • Sharma P.
        • Schaubel D.E.
        • Sima C.S.
        • et al.
        Re-weighting the model for end-stage liver disease score components.
        Gastroenterology. 2008; 135: 1575-1581
        • Biselli M.
        • Gitto S.
        • GRamenzi A.
        Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner?.
        Liver Transpl. 2010; 16: 964-973
        • Leise M.D.
        • Ray Kim W.
        • Kremers W.K.
        A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
        Gastroenterology. 2011; 140: 1952-1960
        • Biselli M.
        • Dall’agata M.
        • Gramenzi A.
        • et al.
        A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score < 18.
        Liver Int. 2015; 35: 184-191